12944 Federal Register / Vol. 86, No. 42 / Friday, March 5, 2021 / Notices 

FEDERAL COMMUNICATIONS 

COMMISSION 

[OMB 3060–0751; FRS 17533] 

Information Collection Being Reviewed 

by the Federal Communications 

Commission Under Delegated 

Authority 

AGENCY: Federal Communications 

Commission. 

ACTION: Notice and request for 

comments. 

SUMMARY: As part of its continuing effort 

to reduce paperwork burdens, and as 

required by the Paperwork Reduction 

Act of 1995 (PRA), the Federal 

Communications Commission (FCC or 

Commission) invites the general public 

and other Federal agencies to take this 

opportunity to comment on the 

following information collections. 

Comments are requested concerning: 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

Commission, including whether the 

information shall have practical utility; 

the accuracy of the Commission’s 

burden estimate; ways to enhance the 

quality, utility, and clarity of the 

information collected; ways to minimize 

the burden of the collection of 

information on the respondents, 

including the use of automated 

collection techniques or other forms of 

information technology; and ways to 

further reduce the information 

collection burden on small business 

concerns with fewer than 25 employees. 

The FCC may not conduct or sponsor 

a collection of information unless it 

displays a currently valid Office of 

Management and Budget (OMB) control 

number. No person shall be subject to 

any penalty for failing to comply with 

a collection of information subject to the 

PRA that does not display a valid OMB 

control number. 

DATES: Written PRA comments should 

be submitted on or before May 4, 2021. 

If you anticipate that you will be 

submitting comments but find it 

difficult to do so within the period of 

time allowed by this notice, you should 

advise the contact listed below as soon 

as possible. 

ADDRESSES: Direct all PRA comments to 

Cathy Williams, FCC, via email to PRA@

fcc.gov and to Cathy.Williams@fcc.gov. 

FOR FURTHER INFORMATION CONTACT: For 

additional information about the 

information collection, contact Cathy 

Williams at (202) 418–2918. 

SUPPLEMENTARY INFORMATION: 

OMB Control No.: 3060–0751. 

Title: Contracts and Concessions, 47 

CFR 43.51. 

Form No.: N/A. 

Type of Review: Extension of a 

currently approved collection. 

Respondents: Business or other forprofit entities. 

Number of Respondents/Responses: 

20 respondents, 20 responses. 

Estimated Time per Response: 6–8 

hours. 

Frequency of Response: On occasion 

reporting requirement. 

Obligation to Respond: Required to 

obtain or retain benefits. The statutory 

authority for this information collection 

is contained in 47 U.S.C. 154, 211, 219 

and 220. 

Total Annual Burden: 140 hours. 

Annual Cost Burden: No cost. 

Privacy Act Impact Assessment: No 

impact(s). 

Nature and Extent of Confidentiality: 

In general, there is no need for 

confidentiality with this collection of 

information. 

Needs and Uses: This collection will 

be submitted as an extension (no change 

in reporting or recordkeeping 

requirements) after this 60-day comment 

period to the Office of Management and 

Budget (OMB) in order to obtain the full 

three-year clearance. 

The Commission has determined that 

the authorized resale of international 

private lines inter-connected to the U.S. 

public switched network would tend to 

divert international message telephone 

service (IMTS) traffic from the 

settlements process and increase the 

U.S. net settlements deficit. The 

information will be used by the 

Commission in reviewing the impact, if 

any, that end-user private line 

interconnections have on the 

Commission’s international settlements 

policy. The data will also enhance the 

ability of both the Commission and 

interested parties to monitor the 

unauthorized resale of international 

private lines that are interconnected to 

the U.S. public switched network. 

Federal Communications Commission. 

Marlene Dortch, 

Secretary. 

[FR Doc. 2021–04616 Filed 3–4–21; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than April 5, 2021. 

A. Federal Reserve Bank of San 

Francisco (Sebastian Astrada, Director, 

Applications) 101 Market Street, San 

Francisco, California 94105–1579: 

1. Riverview Bancorp, Inc., 

Vancouver, Washington; to become a 

bank holding company upon the 

conversion of its wholly-owned 

subsidiary, Riverview Community Bank, 

Vancouver, Washington, from a federal 

savings bank to a Washington statechartered non-member bank. 

Board of Governors of the Federal Reserve 

System, March 2, 2021. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2021–04638 Filed 3–4–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 42 / Friday, March 5, 2021 / Notices 12945 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve proposed 

updates to the approved information 

collection project ‘‘Safety Program in 

Perinatal Care (SPPC)-II Demonstration 

Project.’’ 

DATES: Comments on this notice must be 

received by May 4, 2021. 

ADDRESSES: Written comments should 

be submitted to: Doris Lefkowitz, 

Reports Clearance Officer, AHRQ, by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

Copies of the proposed collection 

plans, data collection instruments, and 

specific details on the estimated burden 

can be obtained from the AHRQ Reports 

Clearance Officer. 

FOR FURTHER INFORMATION CONTACT: 

Doris Lefkowitz, AHRQ Reports 

Clearance Officer, (301) 427–1477, or by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project 

Safety Program in Perinatal Care 

(SPPC)-II Demonstration Project 

The SPPC–II Demonstration Project 

has the following goals: 

(1) To implement the integrated 

Alliance for Innovation on Maternal 

Health (AIM)-SPPC II program in 

birthing hospitals in Oklahoma and 

Texas in coordination with AIM and the 

respective state PQC (Perinatal Quality 

Collaborative); 

(2) To assess the implementation of 

the integrated AIM–SPPC II program in 

these hospitals; and 

(3) To ascertain the short- and 

medium-term impact of the integrated 

AIM–SPPC II program on hospital (i.e., 

perinatal unit) teamwork and 

communication, patient safety, and key 

maternal health outcomes. 

This study is being conducted by 

AHRQ through its contractor, Johns 

Hopkins University (JHU) and the AIM 

program, JHU’s subcontractor, pursuant 

to AHRQ’s statutory authority to 

conduct and support research on 

healthcare and on systems for the 

delivery of such care, including 

activities with respect to the quality, 

effectiveness, efficiency, 

appropriateness and value of healthcare 

services and with respect to quality 

measurement and improvement. 42 

U.S.C. 299a (a)(1) and (2). 

Due to continued pandemic-related 

impacts on the SPPC–II study 

population, we propose to update the 

SPPC–II data collection by (1) 

restructuring and adding questions to 

the approved qualitative interview 

guides to be used with AIM program 

Team Leads and now frontline health 

providers in the summer/fall of 2021 to 

include questions to better understand 

the perceived implementation context; 

and (2) adding focus group discussions 

in the summer/fall of 2022 to assess 

perceptions of implementation and 

sustainability of the SPPC–II Toolkit at 

the hospital level The total burden 

hours resulting from these proposed 

updates to the SPPC–II data collection is 

64 hours. The total estimated annual 

burden hours for SPPC–II are 54,693. 

Method of Collection 

To achieve the goals of this project the 

following updates to the data collections 

will be implemented: 

(a) Qualitative, semi-structured 

interviews with AIM Team Leads and 

frontline staff will be conducted by 

phone or via zoom in the summer/fall 

of 2021 to assess the perceived utility of 

the training and the perceived 

implementation context (including 

barriers, facilitators, and strategies) in 

the context of a reduced scope for 

SPCC–II. In 8 hospitals, one-hour 

interviews with AIM Team Leads (1 per 

hospital) and 30-minute interviews with 

frontline staff (4 per hospital) will be 

conducted. An interview guide 

developed based on the Consolidated 

Framework for Implementation 

Research framework will be used to 

conduct the interviews, together with a 

corresponding consent form. The 

interview guide will be supported by 

the SPPC–II tier level training specific 

handouts. 

(b) Focus group discussions with AIM 

Team Leads and frontline staff will be 

conducted by phone or via zoom in the 

summer/fall of 2022 to assess 

perceptions of implementation and 

sustainability of the SPPC–II Toolkit at 

the hospital level. We will conduct one 

1-hour focus groups with AIM Team 

Leads and frontline staff in each of the 

8 hospitals. An interview guide 

developed based on the Consolidated 

Framework for Implementation 

Research framework will be used to 

conduct the interviews, together with a 

corresponding consent form. 

Estimated Annual Respondent Burden 

Exhibit 1 shows only the estimated 

annualized burden hours for the 

respondents’ time to participate in 

updates to the information collection of 

the SPPC–II Demonstration Project. 

One-hour qualitative interviews will 

be conducted with a total of 8 AIM 

Team Leads and 30-minute qualitative 

interviews with 32 frontline staff in 8 

hospitals. We will also conduct 8 onehour focus group discussions with a 

total of 40 AIM Team Leads and 

frontline staff in the same hospitals. 

The total burden hours resulting from 

the proposed updates to the SPPC–II 

data collection is 64 hours. The total 

annual burden hours are estimated to be 

54,693 hours. 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Hours per 

response 

Total burden 

hours 

Qualitative semi-structured interviews with AIM Team Leads ........................ 8 1 1.00 8 

Qualitative semi-structured interviews with frontline staff ............................... 32 1 0.50 16 

Focus group discussions with AIM Team Leads and frontline staff ............... 40 1 1 40 

Total .......................................................................................................... 80 NA NA 64 

Exhibit 2 shows only the hours and 

cost of updates to the collection. The 

total cost burden of the updated 

collection is estimated to be 

$1,421,576.68 annually. 


jbell on DSKJLSW7X2PROD with NOTICES
12946 Federal Register / Vol. 86, No. 42 / Friday, March 5, 2021 / Notices 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Form name Number of 

respondents 

Total burden 

hours 

Average 

hourly wage 

rate * 

Total cost 

burden 

Qualitative semi-structured interviews with AIM Team Leads ........................ 8 8 $49.83 $398.64 

Qualitative semi-structured interviews with frontline staff ............................... 32 16 49.83 797.28 

Focus group discussions with AIM Team Leads and frontline staff ............... 40 40 49.83 1,993.20 

Total .......................................................................................................... 80 64 ........................ $3,189.12 

* National Compensation Survey: Occupational wages in the United States May 2017 ‘‘U.S. Department of Labor, Bureau of Labor Statistics.’’ 

Weighted mean hourly wage for obstetrician-gynecologists ($113.10; occupation code 29–1064; 30%); nurse-midwives ($49.83; occupation code 

29–1161; 30%); registered nurses ($35.36; occupation code 29–1161; 20%); and nurse practitioners ($51.86; occupation code 29–1171; 20%). 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, 44 U.S.C. 3501–3520, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) Whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ’s health care research and health 

care information dissemination 

functions, including whether the 

information will have practical utility; 

(b) the accuracy of AHRQ’s estimate of 

burden (including hours and costs) of 

the proposed collection(s) of 

information; (c) ways to enhance the 

quality, utility and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: March 1, 2021. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2021–04502 Filed 3–4–21; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on Management of Infantile 

Epilepsy 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for Supplemental 

Evidence and Data Submissions. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

Management of Infantile Epilepsy, 

which is currently being conducted by 

the AHRQ’s Evidence-based Practice 

Centers (EPC) Program. Access to 

published and unpublished pertinent 

scientific information will improve the 

quality of this review. 

DATES: Submission Deadline on or 

before April 5, 2021. 

ADDRESSES: 

Email submissions: epc@

ahrq.hhs.gov. 

Print submissions: 

Mailing Address: Center for Evidence 

and Practice Improvement, Agency for 

Healthcare Research and Quality, 

ATTN: EPC SEADs Coordinator, 5600 

Fishers Lane, Mail Stop 06E53A, 

Rockville, MD 20857. 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers Lane, 

Mail Stop 06E77D, Rockville, MD 

20857. 

FOR FURTHER INFORMATION CONTACT: 

Jenae Benns, Telephone: 301–427–1496 

or Email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Centers (EPC) 

Program to complete a review of the 

evidence for Management of Infantile 

Epilepsy. AHRQ is conducting this 

systematic review pursuant to Section 

902 of the Public Health Service Act, 42 

U.S.C. 299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Management of Infantile 

Epilepsy, including those that describe 

adverse events. The entire research 

protocol is available online at: https://

effectivehealthcare.ahrq.gov/products/ 

management-infantile-epilepsy/ 

research-protocol. 

This is to notify the public that the 

EPC Program would find the following 

information on Management of Infantile 

Epilepsy helpful: 

D A list of completed studies that 

your organization has sponsored for this 

indication. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

D For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements: Study number, study period, 

design, methodology, indication and 

diagnosis, proper use instructions, 

inclusion and exclusion criteria, 

primary and secondary outcomes, 

baseline characteristics, number of 

patients screened/eligible/enrolled/lost 

to follow-up/withdrawn/analyzed, 

effectiveness/efficacy, and safety results. 

D A list of ongoing studies that your 

organization has sponsored for this 

indication. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including a study number, the 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, and primary and secondary 

outcomes. 

D Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

organization for this indication and an 

index outlining the relevant information 

in each submitted file. 

Your contribution is very beneficial to 

the Program. Materials submitted must 

be publicly available or able to be made 

public. Materials that are considered 

confidential; marketing materials; study 

types not included in the review; or 

information on indications not included 

in the review cannot be used by the EPC 

Program. This is a voluntary request for 

information, and all costs for complying 


jbell on DSKJLSW7X2PROD with NOTICES